Please assess the completion status of the following clinical trial:

Trial Title: Evaluating the Impact of Prostate Only Versus Pelvic Radiation for N+ Prostate Cancer.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Histological proven carcinoma of the prostate~* Positive lymph nodes found on extended pelvic dissection (EPLND) defined as:~* Removal of the lymphatic tissue in the obturator fossa + along the external iliac vessels + additional complete resection of the lymph nodes (lnn) along, medially and laterally to, the hypogastric vessels~* If technically feasible: removal of lnn along the common iliac vessels~* Removal of ≥10 lnn~* Treatment of the primary tumor by either radical prostatectomy or EBRT~* Willing to receive androgen deprivation therapy~* World health organization 0-2~* Written informed consent~Exclusion Criteria:• \>4 positive lnn found on EPLND~* Prior pelvic irradiation~* Other primary tumor (except for non-melanoma skin tumors) diagnosed \<5 years before enrollment~* Presence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Prostate(bed) only (Type: EXPERIMENTAL): external beam radiotherapy limited to the prostate(bed)
- Prostate(bed) and pelvis (Type: ACTIVE_COMPARATOR): external beam radiotherapy to the prostate(bed) and pelvic lymph node regions

Based on this trial design, predict the completion outcome and termination type (if applicable).